We highlight the possibility that an overflow of TSH-receptor antigens following RAI treatment in patients with metastatic thyroid cancer can lead to the formation of TSH-receptor antibodies, presenting as Graves ophthalmopathy many years following total thyroidectomy. The gene discussed is TSHR; the disease is Graves ophthalmopathy.